Table 4. Propensity-adjusted multiple logistic regression for risk factors associated with progression towards severe disease or death at day 14.
| Population: patients with baseline suPAR ≥ 6ng/mL who fulfilled the prescriptive criteria for anakinra (n = 105) | ||||||
|---|---|---|---|---|---|---|
| Variable | Univariable | Multivariable | ||||
| OR1 | 95% CI1 | p-value | OR1 | 95% CI1 | p-value | |
| Age (years) | 1.07 | 1.04, 1.12 | < 0.001 | 1.09 | 1.05, 1.14 | < 0.001 |
| Anakinra | 0.34 | 0.13, 0.79 | 0.016 | 0.32 | 0.12, 0.82 | 0.021 |
| PaO2/FiO2 ratio | 1.00 | 0.99, 1.00 | 0.243 | 0.99 | 0.98, 1.00 | 0.051 |
OR: Odds Ratio; CI: Confidence Interval.
Severe disease is defined according to the WHO Clinical Progression Scale (WHO-CPS score 6–10).